ESR1 rs569033466: Regulatory Variant and Hormone Sensitivity
The genetic variant rs569033466 is an uncommon single-nucleotide polymorphism located in a regulatory region of the ESR1 gene. This gene encodes estrogen receptor alpha, a critical protein responsible for mediating cellular responses to estrogen throughout the body. Research associates this variant with subtle differences in reproductive steroid hormone responsiveness, though current clinical evidence remains moderate and non-diagnostic.
What each genotype means
Typical hormone receptor expression
You carry two copies of the common C allele in the ESR1 regulatory region. Research indicates this genotype is associated with baseline estrogen receptor expression and typical responsiveness to endogenous steroid hormones. Because this represents the baseline profile, published studies do not report altered reproductive steroid signaling for this genotype.
Carried by more than 99.9% of individuals across all major global populations evaluated in gnomAD.
Altered estrogen signaling responsiveness
You have one copy of the rare regulatory T allele alongside the common C allele. Preliminary functional research suggests this variant sequence can alter ESR1 transcriptional activity and modulate cellular responsiveness to reproductive steroid hormones, though current evidence remains moderate and population-level studies are limited. If you are taking or evaluating hormone therapies, discuss relevant treatment monitoring and medication responses with your clinician or pharmacist.
Extremely rare, observed in fewer than 1 in 1,000 individuals across worldwide populations (gnomAD MAF < 0.0005).
Altered estrogen signaling responsiveness
You carry two copies of the rare regulatory T allele in ESR1. Research indicates this altered regulatory region may influence estrogen receptor 1 expression and sensitivity to reproductive steroids, although direct clinical data for homozygotes remain scarce due to the variant's extreme rarity. If you are prescribed hormonal treatments or related therapies, consult your clinician or pharmacist to discuss your individual response profile.
Exceptionally rare globally, with an estimated prevalence well under 1 in 1,000,000 individuals.
Understanding rs569033466 and Genomic Location
The variant designated rs569033466 is cataloged in dbSNP as an uncommon sequence alteration mapped to human chromosome 6 within the estrogen receptor 1 (ESR1) gene locus. Rather than causing a direct change in the protein's primary amino acid sequence, this single-nucleotide polymorphism is positioned in a non-coding regulatory segment. Non-coding elements, including promoters, enhancers, and untranslated regions, serve as docking stations for transcription factors and transcriptional machinery. When single nucleotide changes occur in these regions, they can subtly alter how efficiently the transcription machinery binds to DNA. Consequently, the presence of an alternate allele at rs569033466 has been investigated for its potential to alter the baseline expression levels or regulatory responsiveness of the downstream receptor.
The Biological Function of ESR1
The ESR1 gene provides cellular instructions for synthesizing estrogen receptor alpha (ER-alpha), a ligand-activated transcription factor belonging to the nuclear hormone receptor superfamily. When circulating estrogens—such as estradiol—bind to ER-alpha, the receptor undergoes dimerization, translocates to the cell nucleus, and binds directly to specific estrogen response elements in genomic DNA. This process modulates the transcription of hundreds of genes involved in tissue maintenance, cellular growth, bone density, cardiovascular regulation, and reproductive development. Because estrogen receptors are ubiquitous across breast, uterine, ovarian, vascular, and neural tissues, any genetic variation that modifies ESR1 transcription can theoretically influence systemic sensitivity to both endogenous estrogen production and exogenous hormone exposures.
Research Associations and Evidence Strength
Scientific investigations catalog rs569033466 as a functional regulatory region variant with moderate evidence linking it to altered responsiveness to reproductive steroid hormones. In molecular and epidemiological studies, alterations within ESR1 regulatory domains have been examined for their relationship to endocrine traits, varying physiological responses to hormone therapy, and steroid receptor modulation. However, the existing evidence for rs569033466 specifically is moderate and largely derived from statistical associations in target cohorts. It is crucial to distinguish these statistical associations from definitive causal pathology. Variant carriers do not exhibit guaranteed endocrine dysfunction, and the variant has not been classified as a high-penetrance Mendelian disease allele in diagnostic databases such as ClinVar.
Global Frequency and Population Distribution
Reference population databases, notably the Genome Aggregation Database (gnomAD), show that rs569033466 is an exceptionally uncommon variant worldwide. With a minor allele frequency documented at under 0.0005 (less than 0.05%), it appears in only a very tiny fraction of sequenced alleles globally. Because of its scarcity, detailed subpopulation breakdowns across diverse continental ancestries remain limited in contemporary literature. In large-scale population sequencing cohorts, the vast majority of individuals carry two copies of the common reference allele. The extreme rarity of the minor allele means that homozygous alternate genotypes are virtually unobserved in standard public databases, emphasizing that this variant represents low-frequency variation rather than a typical common polymorphism.
Clinical Utility: What You Can and Cannot Do
Discovering an alternate allele at rs569033466 on a consumer genetic report provides educational insight into genomic diversity, but it cannot be used to diagnose any disease or dictate clinical management. While the variant is tied to moderate trait-level shifts in hormone responsiveness, it does not reliably predict outcomes for fertility, reproductive health, or estrogen-related disorders on an individual level. Readers must not initiate, alter, or discontinue hormone replacement therapies, oral contraceptives, or any endocrine medications based on this genetic finding. Anyone with clinical concerns regarding hormone balance or reproductive health should review their personal medical history with a qualified physician or genetic counselor.
How common is this variant?
Across global sequencing datasets in gnomAD, rs569033466 is rare with an overall minor allele frequency of less than 0.0005, meaning the alternative allele is observed in fewer than 1 in 2,000 sequenced chromosomes.
Frequently asked questions
What does the ESR1 rs569033466 variant mean for my health?
Carrying this variant has been linked in population research to subtle variations in how cells respond to steroid hormones like estrogen. However, the scientific evidence is moderate, and it does not mean you have a disease or guaranteed endocrine issue.
Does having rs569033466 affect my response to hormone replacement therapy?
While ESR1 regulatory variants are studied for differences in hormone sensitivity, current evidence is insufficient to guide personal medication decisions. You should always discuss hormone treatments, dosing, and risks directly with your physician or pharmacist.
How common is rs569033466 in the general population?
This variant is very rare, with a minor allele frequency below 0.05% in reference population databases like gnomAD. Almost all tested individuals carry two copies of the standard reference allele.
Can rs569033466 diagnose breast cancer or reproductive disorders?
No, rs569033466 is classified as a trait-associated regulatory marker, not a diagnostic or pathogenic mutation. It cannot be used alone to evaluate your risk of breast cancer or reproductive diseases.
Sources & further reading
Educational information only, last refreshed 9/11/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs569033466?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in ESR1
This variant in the estrogen receptor 1 gene is associated with human reproductive behavior and influences estrogen-responsive gene expression.
This variant in the estrogen receptor 1 gene is associated with an increased risk of endometriosis and may influence cognitive aging.
Estrogen receptor 1 variant associated with altered circulating estradiol levels, follicular maturation, and variability in age at natural menopause.
Variant in estrogen receptor 1 associated with variation in female reproductive timing, including age at menarche and natural menopause onset.
Common polymorphism in estrogen receptor alpha (ESR1) affecting target tissue responsiveness to estrogen, recurrent pregnancy loss risk, and bone-reproductive axis interactions.
Estrogen receptor 1 regulatory variant associated with variation in timing of menarche and bone density response to sex hormones.